ELTX

NASDAQStock

Elicio Therapeutics, Inc.

$12.04+1.14 (+10.46%)

52-Week Range

$4.76

$13.84

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.68

Volume

132.1K

Avg Volume

171.5K

Performance

+29.61%

+27.93%

+8.13%

YTD

+35.40%

+40.65%

-39.93%

Price Chart

ETF Exposure

ELTX is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.02%	25,088	$296K	$1.27B	0.60%
VXF	Vanguard Extended Market ETF	0.00%	120,683	$917K	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	18	$194	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	675	$7K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	3	$33	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	384,801	$2.9M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	2,023	$21K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	174	$2K	$1.29B	0.17%

About ELTX ETF Exposure

Elicio Therapeutics, Inc. (ELTX) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $12.04. Investors can gain exposure to ELTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ELTX, sorted by portfolio weight.